These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Novel pharmacological targets for the treatment of Parkinson's disease. Schapira AH; Bezard E; Brotchie J; Calon F; Collingridge GL; Ferger B; Hengerer B; Hirsch E; Jenner P; Le Novère N; Obeso JA; Schwarzschild MA; Spampinato U; Davidai G Nat Rev Drug Discov; 2006 Oct; 5(10):845-54. PubMed ID: 17016425 [TBL] [Abstract][Full Text] [Related]
6. Treatment of levodopa-induced motor complications. Stocchi F; Tagliati M; Olanow CW Mov Disord; 2008; 23 Suppl 3():S599-612. PubMed ID: 18781681 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease. Chen JJ; Swope DM; Dashtipour K Clin Ther; 2007 Sep; 29(9):1825-49. PubMed ID: 18035186 [TBL] [Abstract][Full Text] [Related]
8. An open study with reversible MAO-A inhibitors in complicated Parkinson's disease. Ruggieri S; Fabbrini G; Bramante L; DePandis F; Stocchi F; Barbanti P; Vacca L; Manfredi M Adv Neurol; 1996; 69():595-8. PubMed ID: 8615185 [No Abstract] [Full Text] [Related]
9. Treatment of Parkinson's disease in Thailand: review of the literature and practical recommendations. Bhidayasiri R; Ling H J Med Assoc Thai; 2009 Jan; 92(1):142-54. PubMed ID: 19260256 [TBL] [Abstract][Full Text] [Related]
11. Parkinson's disease therapy: treatment of early and late disease. Jankovic J Chin Med J (Engl); 2001 Mar; 114(3):227-34. PubMed ID: 11780303 [TBL] [Abstract][Full Text] [Related]
12. How should we treat a patient with early Parkinson's disease? Tsouli S; Konitsiotis S Int J Clin Pract; 2010 Aug; 64(9):1210-9. PubMed ID: 20653797 [TBL] [Abstract][Full Text] [Related]
13. Treatment options for early Parkinson's disease. Stacy M; Brownlee HJ Am Fam Physician; 1996 Mar; 53(4):1281-7. PubMed ID: 8629572 [TBL] [Abstract][Full Text] [Related]
14. Dopamine agonist-based strategies in the treatment of Parkinson's disease. Antonini A; Barone P Neurol Sci; 2008 Dec; 29 Suppl 5():S371-4. PubMed ID: 19381765 [TBL] [Abstract][Full Text] [Related]
15. A review of intermittent subcutaneous apomorphine injections for the rescue management of motor fluctuations associated with advanced Parkinson's disease. Chen JJ; Obering C Clin Ther; 2005 Nov; 27(11):1710-24. PubMed ID: 16368444 [TBL] [Abstract][Full Text] [Related]
17. Parkinson's disease. Therapeutic strategies to improve patient function and quality of life. Danisi F Geriatrics; 2002 Mar; 57(3):46-50; quiz 52. PubMed ID: 11899548 [TBL] [Abstract][Full Text] [Related]
18. Advanced strategies for treatment of Parkinson's disease: the role of early treatment. Jann MW Am J Manag Care; 2011 Oct; 17 Suppl 12():S315-21. PubMed ID: 22087552 [TBL] [Abstract][Full Text] [Related]
19. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis. Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614 [TBL] [Abstract][Full Text] [Related]
20. Drug selection and timing of initiation of treatment in early Parkinson's disease. Schapira AH; Olanow CW Ann Neurol; 2008 Dec; 64 Suppl 2():S47-55. PubMed ID: 19127579 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]